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Introduction
Despite rapid progress in science, cancer remains 
one of the greatest challenges to humanity. Based on 
statistics, almost half of all deaths in middle age are due to 
cancer, the incidence of which depends on factors such as 
genetic background (Karim-Kos et al., 2008). Meanwhile, 
breast cancer is responsible for a substantial part of 
cancer occurrences. Currently, surgery, radiotherapy 
and chemotherapy are widely used for treatment of this 
kind of cancer (Kirkwood et al., 2012). Nevertheless, 
due to limited effects of the present methods or their side 
effects, search for more effective and harmless treatments 
is a prominent priority. Regardless of the mentioned 
limitations, resistance to chemotherapy occurs in a large 
number of cancer patients (Gottesman et al., 2002). 
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Logically, successful methods should be referred to 
the strategies which could return the factors causing 
tumorigenesis to their normal state.
One of the main proteins involved in cancer 
prevention is P53, which is encoded by the TP53 gene 
(Surget et al., 2014). Abnormality in the structure or 
function of this gene has been reported in many cancers. 
In addition to the direct effect on the inhibition of 
tumorigenesis, this protein can also neutralize the effects of 
anti-apoptotic proteins (di Pietro et al., 2012). One of 
these anti-apoptotic proteins is survivin, which prevents 
the programmed cell death by inhibiting caspases 
(Karami et al., 2013). This makes P53 as a suitable target 
for cancer treatment. 
Epigenetic mechanisms like DNA methylation are 
considered as important approaches for regulation of 
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gene expression in cells and tissues (Meng et al., 2011). 
Although changes in gene methylation patterns do not result 
in the DNA sequence alteration, they could largely affect 
the gene expression levels (Ghavifekr Fakhr et al., 2013). 
Change in the status of DNA methylation, particularly 
in the gene promoter area, is occurred as hyper or hypo 
methylation (Richards and Elgin, 2002). A decrease in 
P53 expression by epigenetic mechanisms, particularly 
DNA methylation, has been reported in 50% of human 
cancers (Lengauer and Issa, 1998). Fortunately, unlike 
genetic changes that are almost irreversible, epigenetic 
abnormalities are potentially rectifiable (Cai et al., 2011). 
This feature makes an incentive for the production and 
use of epi-drugs to return the malignant state to normal.
In the previous studies, we analyzed the cytotoxic 
effects of the extracts from Scrophularia plants on MCF-7 
breast cancer cells (Orangi et al., 2016). In the present study, 
cell death ELISA and TUNEL (Terminal deoxynucleotidyl 
transferase dUTP nick end labeling) assays were 
performed to confirm the occurrence of apoptosis in 
MCF-7 cells treated by SADCM. Furthermore, after 
exposure to the mentioned extract, methylation pattern of 
TP53 gene was assessed by MSP test. Finally, changes in 
TP53 and survivin genes expression were evaluated by 
quantitative real time PCR.
Materials and Methods
Extract Preparation 
S. atropatana plant was collected at the end of 
the growing season from East Azerbaijan province- Iran. 
The stems and leaves were thoroughly washed with distilled 
water and dried at room temperature. The extraction of 
dry powder was done using DCM (dichloromethane) 
in a Soxhlet apparatus. The resulting extracts were 
completely evaporated using a rotary machine at 45oC and 
low pressure and were stored in refrigerator. To provide 
the desired concentration from the plant extracts for 
the MCF-7 cells treatment, 0.02 g of extract was dissolved 
in 100 ml DMSO (Dimethyl sulfoxide) and diluted 
with RPMI-1640 medium. The solution was sterilized 
using Millipore syringe filters (0.2 μm) and stored in 
the refrigerator.
Cell culture
The MCF-7 breast adenocarcinoma cell line 
from human origin was purchased from Pasteur 
Institute of Iran. Cells were cultured in RPMI– 1640 
medium (10.39 g/liter, Sigma) supplemented with 10% 
Fetal Bovine Serum (Gibco), penicillin (100U/ml) and 
streptomycin (100 µg/ml) (both from Sigma). The cells 
were then incubated at 37°C and 5% CO2.
TUNEL assay
TUNEL kit (Roche Diagnostics, Germany) was 
used for detection of DNA fragmentation, a prominent 
hallmark of apoptosis, in cells treated with SADCM. 
103 of MCF-7 cells were seeded in 96 well culture 
plates in triplicates. 24 h later, the cells were treated with 
200 and 400 mg per ml concentrations of SADCM. IC50, 
the concentration that gives growth inhibition by 50% was 
determined in previous study which its value was 200 mg 
per ml. The cells treated with DMSO were considered as 
negative control. After 24 h of treatment, TUNEL assay 
was carried out according to the protocol recommended 
by manufacturer. In summary, cells were fixed for one 
hour at room temperature in a solution containing 4% 
(w/v) of paraformaldehyde in PBS (pH 7.4). The cells 
then were washed 2 times with PBS (Phosphate buffered 
saline) and incubated with blocking solution for 10 
minutes at room temperature. Subsequently, the cells were 
washed again with PBS buffer and incubated on ice with 
permeabilisation solution for 2 minutes. After washing 
with PBS, 50 microliters of TUNEL reaction mixture 
containing the TdT enzyme was added to the wells and the 
cells were incubated for one hour at 37°C. In this stage, 
the TdT enzyme adds labeled nucleotides to the 3’ end of 
broken DNA strands. After three times of washing with 
PBS, cells were incubated with 50 μl of converter-POD 
sterptavidin HRP (Horseradish peroxidase) solution for 
30 minutes in the dark. After washing, the cells were 
incubated with DAB (Sigma) and analyzed by an inverted 
light microscope.
Cell Death Detection ELISA 
A number of 104 viable cells were cultured in 96 
well culture plates in triplicates. 24 h after treatment 
with IC50 concentrations of SADCM, the cells were 
assessed for apoptosis and necrosis using cell death 
detection ELISA kit (Roche Diagnostics GmbH, 
Germany). The procedure was performed according to 
the manufacturer’s recommendations. In brief, cells lysates 
(for apoptosis detection) and culture supernatants 
(for detection of necrosis) were incubated in a streptavidin 
coated microtiter plate. The simultaneous attaching of 
both “biotin labeled anti histone” and “anti- DNA- POD” 
antibodies was utilized for quantification of histone 
associated DNA in mono and oligonucleosome forms. After 
adding the appropriate substrate and color development, 
100 μl of stop solution was added to each well and the 
absorbance were measured spectrophotometrically using 
an ELISA plate reader at 405 nm. The cells treated with 
DMSO were considered as negative control in this test. 
Methylation specific PCR
MSP was employed to investigate the possible 
impacts of SADCM on methylation status in CpG 
islands of TP53 gene.
The TP53 gene sequence was obtained from NCBI 
databases and CpG islands in the upstream region and within 
the gene were analyzed using the UCSC database. Predicting 
the occurrence of likely promoter regions in the selected 
CpG islands was done using online promoter prediction 
software (http://rulai.cshl.edu/cgi-bin/CSHLmpd2/
promExtract.pl?species=Human.) and according to 
the literature (Almeida et al., 2009). The required primers, 
including methylated (M) and unmethylated (U), were 
designed to assess CpG islands using MethPrimer software 
(http://www.urogene.org/methprimer/). Subsequently, the 
designated primers were blasted using the online Methblast 
software (http://medgen.ugent.be/methBLAST/).
DNA Extraction from MCF-7 cells was carried out using 
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protocol. The extracted RNA was evaluated by the 
Eppendorf Biophotometer and 3µg of this RNA was 
utilized for cDNA synthesis using the RevertAid™ 
(First Strand cDNA Synthesis Kit, Fermantas). CDNA 
synthesis was done according to the recommended 
protocol using random hexamer primers.
QRT- PCR was performed using the specific primers 
listed in Table 1. Beta actin was employed as normalizer 
gene. Thermo cycling started with 3 min of initial hold 
at 94˚C and followed by 45 cycles of 94°C for 10 s, 
58°C for 40 s and 72° C for 20 s. the reaction mixture 
used for qRT-PCR contained: 10 µl of SYBR premix 
(RR820L, Takara), 0.5 µl of forward and reverse primers 
in a concentration of 4 µM, 0.5 µl of cDNA and nuclease 
free water up to 20 µl. Relative expressions of TP53 and 
survivin mRNAs were calculated using delta-delta Ct 
method (Livak and Schmittgen, 2001).
Results
TUNEL Apoptosis assay
The TUNEL assay was used to confirm the occurrence of 
apoptosis 24 hours after the treatment with SADCM. 
Using this test, DNA fracturing resulted from apoptosis 
was appeared in brown color. Despite, brown precipitates 
were not observed in the untreated cells (Figure 1).
Cell death ELISA assay for quantification of apoptosis 
and necrosis
The Cell death ELISA kit was utilized to evaluate 
the cell death induced by SADCM. Based on the results of 
the MTT test from previous studies, the IC50 concentration 
(200 mg/ml) and 400 mg/ml concentration were used for 
this assay. According to the results, a significant increase 
in apoptosis rate was detected in cells treated with 
the extract. By increasing the concentration from 200 to 
400 micrograms, the rate of apoptosis was also increased 
(Figure 2).
MSP test 
MSP on TP53 promoter with methylated and 
unmethylated primers showed that, the extract had 
considerable effects on the methylation status of this gene. 
There was a 166 bp band with the methylated primer in the 
untreated cells that represents the methylated status of P53 
the DNeasyTM extraction kit (69581, Qiagen) based on 
the recommended protocol. The extracted DNA was 
analyzed by Eppendorf BioPhotometer spectrophotometre 
in 260 nm and agarose gel electrophoresis. The extracted 
DNA was treated with the sodium sulfite (SBS). In this 
process, all unmethylated cytosines were converted 
to uracils while methylated cytosine remained intact. 
For this purpose, 1 µg DNA (in a 10 microliters volume) 
was added to 40 microliters of nuclease free water. Then, 
5.5 microliters of NaOH (2M) was added and incubated 
for 20 minutes at 37° C. Subsequently, 30 microliters 
of freshly prepared 10 mM hydroquinone and 520 
microliters of sodium bisulfite (freshly prepared) were 
added to the reaction tube. Finally, the solution was 
covered with mineral oil and incubated for 16 hours at 
50°C. In order to perform desulfonation, 22 microliters of 
3M sodium hydroxide was added and incubated for 5 
minutes at room temperature. DNA was then precipitated 
using ethanol- ammonium acetate method and dissolved 
in 30 microliters of nuclease free water.
For each studied sample, two PCR reactions, one with 
M primer and the other with U primer, were performed. 
Amplification with M primers was considered as an 
indicator of methylation in CpG sites within the primer 
sequences and PCR products resulted from U primers 
indicated the absence of methylation. Furthermore, 
amplification with both M and U primers was regarded as 
partial methylation. Primer sequences for Methylated-and 
unmethylated MSP are included in Table 1. List of 
ingredients used for methylated and un-methylated MSP 
are also provided in Table 2. Thermo cycling comprised of: 
one cycle of initial denaturation at 94oC for 5 min and 35 
cycles of 94oC for 30 sec, 52oC for 40 sec and 72 for 40 
sec. A final extension step at 72oC was also considered 
for 5 min. After performing PCR, electrophoresis on 
polyacrylamide gel with silver nitrate staining was used 
for detection of the amplicons.
Quantitative Real Time PCR for assessment of TP53 and 
survivin genes expression 
For this purpose, a number of 500,000 cells were 
cultured in 6-well plates. The cells were treated with 
DCM extracts of the SA plant in IC50 concentration. 
After 12 hours, total RNA was extracted using the RNX 
Plus kit (Cinnagen, Iran) according to the manufacturers’ 
Test type Primers Sequence (5’ to 3’) Amplicon size (bp)
Methylation Specific PCR P53 M-F CGT CGT ATT TCG GAT TAG ATT TC 166
P53 M-R AAA AAA ACG TAA ACG CTT CTC CG
P53 U-F GGT TGT TGT ATT TTG GAT TAG ATT TT 170
P53 U-R AAA AAA AAC ATA AAC ACT TCT CAC C
qRT-PCR Survivin-F GGACCACCGCATCTCTACAT 194
Survivin-R CAACGCGAAAGGAAAGACAG
β–actin-F TCC CTG GAG AAG AGC TAC G 131
β–actin-R GTA GTT TCG TGG ATG CCA CA
TP53-F TCA ACA AGA TGT TTT GCC AAC TG  118
TP53-R ATG TGC TGT GAC TGC TTG TAG ATG  
Table 1. Features of the Primers which Were Used in This Study
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gene promoter. The intensity of the mentioned band was 
largely decreased after treatment with the herbal extract. 
This was an evident of a change from hypermethylation to 
hypomethylation state (Figure 3).
MSP with unmethylated primers resulted in a 170 bp 
band in the N -- , untreated and also treated cells). Presence 
of both 166 and 170 bp bands in M- and M+ groups 
indicates the partial methylation of TP53 gene promoter 
and the presence of unmethylated cytosines (Figure 4).
TP53 and survivin genes expression
Real time PCR was exploited for assessment of 
changes in TP53 and Survivin genes’ expression in MCF-7 
cells treated with SADCM. Results indicated a significant 
increase in TP53 gene expression compared to untreated 
controls (Figure 5A). Moreover, a noticeable effect on the 
survivin gene expression was observed, where exposure to 
the extract was led to a significant decrease in mRNA 
expression (Figure 5B).
Discussion
Breast cancer is a common type of cancer among women 
with a substantial rate of morbidity and mortality. Cancer 
patients usually experience different kinds of treatment 
strategies. However, herbal treatments because of their 
lower side effects have attracted a great deal of interest. 
Natural compounds with herbal origins such as Vinca 
Alkaloids, Taxanes, podophyllotoxin, Camptothecins are 
Figure 3. MSP with Methylated Primer Pairs. 
The amplicon in 166 bp size, represents a methylated 
status. N --, control DNA extracted from peripheral blood 
(neither methylated nor treated with SBS); N ++, control 
DNA extracted from peripheral blood (methylated using 
M.SssI CpG Methyltransferase enzyme and treated with 
SBS); M -, untreated MCF-7 cells; M +, MCF-7 cells 
treated with SADCM, L: 100 bp Ladder.
Table 2. List of the Ingredients Used for Methylation 
Specific PCR (MSP) 
PCR ingredients Un-methylated 
(µl)
Methylated 
(µl)
Input DNA 4 5
Taq DNA Polymerase (Fermentas) 0.25 0.25
PCR Buffer (Fermentas) 2.5 4
Primer-F (30μM) 0.5 0.25
Primer-R (30μM) 0.5 0.25
dNTPs (2.5mM, Fermentas) 1 0.5
MgCl2 (25 mM, Fermentas) 2 2
DMSO (Fermentas) 0.5 -
Nuclease free H2O 13.75 12.75
Total volume 25 25
Figure 1. Apoptotic Effects of SADCM on MCF-7 Cells 
are Observed by TUNEL Assay. A, Non Treated Cells; 
B, MCF-7 Cells Treated with SADCM. Arrows Indicate 
the Apoptotic Cells.
Figure 2. Comparison of Apoptosis and Necrosis 
between Untreated MCF-7 Cells and the Cells Treated 
with 200 and 400 mg/ml Concentrations of SADCM in 
24 hours (P < 0.01). 
Figure 4. N --, Control DNA Extracted from 
Peripheral Blood (neither methylated nor treated with 
SBS); M -, untreated MCF-7 cells; M +, MCF-7 cells 
treated with SADCM; L, 100 bp Ladder.
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the most commonly used FDA approved compounds for 
the treatment of a wide range of cancers including breast, 
ovarian and lung cancers (Hosseini et al., 2015). Similarly, 
some derivatives from Scrophularia plants are being used 
in the treatment of several diseases including inflammation 
and infection (Uddin et al., 2011). In this regard, in 
previous studies, we have evaluated the cytotoxic effects 
of extracts and fractions derived from some Scrophularia 
species on a variety of cancerous cells (Hosseini et al., 
2015; Orangi et al., 2016). Furthermore, the increased 
expression of apoptosis indicator genes including 
Caspase-3 and Caspase-9 besides down-regulation of 
anti-apoptotic genes such as Bcl-2 gene confirmed the 
potential of these compounds in the treatment of cancer. 
In the present study, we further confirmed the apoptotic 
effects of SADCM on MCF-7 cells by cell death ELISA 
and TUNEL assays. Uncovering the mechanisms by which 
the bioactive compounds exert their anticancer effects, 
could be a valuable finding for better understanding 
of the factors involved in the tumorigenesis and 
treatment process. Epigenetic changes are one of the 
most prominent alterations which play important roles 
in various types of cancer, either in the early phase or 
late phase. Cytosine methylation at CpG dinucleotides, 
especially in the promoter region of antitumor genes, 
is an important epigenetic change which can unusually 
change their transcription (Ma et al., 2010). In other words, 
the hyper-methylation of CpG islands in promoter region 
could be correlated with transcriptional silencing. The 
epigenetic changes are reversible alterations, which do 
not affect the DNA sequence. Hence, finding effective epi-
drugs especially from plant origin to reverse the epigenetic 
changes to the normal state has recently attracted a 
great deal of attention (Hatzimichael and Crook, 2013). 
In a study, Chrysin, a flavonoid extracted from Oroxylum 
indicum, exhibited anticancer impacts on A375 melanoma 
cells via the normalization of histone acetylation and 
chromatin organization (Pal-Bhadra et al., 2012). 
In another research, Mahanin, an alkaloid from plant 
origin, has been used in returning hyper- methylation of 
the tumor suppressor gene RASSF1A in prostate cancer. 
Also, a reversal of epigenetic changes in colorectal 
carcinoma by active components extracted from Boswellia 
serrata plant is reported. Silencing of tumor suppressor 
gene TP53 is reported in several cancers (Mirza et al., 
2002; Gopisetty et al., 2006; Ramezani et al., 2012) which 
makes it a fascinating therapeutic target. In this regard, 
the present study aimed to investigate the effects of the 
mentioned extract on methylatin status of TP53 gene 
promoter and consequently its expression levels by using 
the MSP test and qRT –PCR respectively. For this purpose, 
we utilized the MSP test, as a powerful technique to 
determine the methylation changes in this gene. Gong et 
al., also employed the MSP test to detect the potential of 
Danshen compounds on reverting the methylation status 
of Aurora A Gene in breast cancer (Gong et al., 2012).
According to MSP results, TP53 promoter in MCF-7 
cells was in both methylated and unmethylated situation 
(partially methylated). Treatment with SADCM could 
remove the majority of methyl groups from this region 
and restore the methylation changes which were leading to 
lower gene expression to normal. Therefore, according to 
real time PCR results, a significant increase in TP53 
mRNA expression was evident. 
On the other hand, tumor formation and progression 
is closely associated with apoptosis impairment (Van De 
Voorde et al., 2012). Survivin is a protein encoded by 
the BIRC5 gene that is over expressed in most human 
cancers.This protein is a member of the apoptosis 
suppressor family (IAP) that inhibits apoptosis through 
both intrinsic and extrinsic pathways by suppressing 
caspases (Hosseini et al., 2015; Sah et al., 2006). Today, 
anti-apoptotic effect of this gene is moderated by strategies 
such as RNA interference methods. These studies suggest 
that down regulating the survivin gene leads to revival of 
the apoptosis pathway and a decrease of tumorigenesis 
(Karami et al., 2013; Montazami et al., 2015).
In addition, several studies indicated that the increased 
expression of TP53 gene inhibits survivin expression 
(Mirza et al., 2002). Accordingly, P53 protein not only 
could have a direct role in tumor suppression, but it could 
play a complementary role by overshadowing the survivin. 
The results of quantitative RT- PCR showed that, survivin 
gene expression was also reduced after treatment with 
Figure 5. mRNA Expression Levels in Untreated Cells Versus MCF-7 Cells Treated with 200 and 400 mg/ml 
Concentrations of SADCM in 24 h; A, TP53 and B, survivin (P < 0.01).
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the extract and this may be a consequence of P53 activity. 
Accordingly, SADCM could be considered as a potential 
source for production of cancer epi-drugs.
The apoptotic effect of SADCM on MCF-7 breast 
cancer cells was confirmed by cell death ELISA and 
TUNEL assays. According to the MSP and qRT-PCR 
results, this extract could drastically restore the methylation 
status of the TP53 gene and its expression. A decreased 
expression of the apoptotic gene survivin, which is 
expected to be influenced by P53 protein, was also 
evident. Consequently, SA could be considered for further 
investigations in production of cancer epi-drugs.
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